The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Artursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Self-citationEffect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 765
Self-citationChitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Advances in Chitin and Chitosan
(1992) · Springer eBooks · doi:10.1007/978-94-011-5942-5 · Cited by 583
Vårum, K. M., Antohonsen, M. W., Grasdalen, H., & Smidsrød, O. (1991) · Carbohydrate Research · doi:10.1016/0008-6215(91)84142-2 · Cited by 464
Self-citationpH and c.d. measurements on a fully deacetylated chitosan: application to CuII—polymer interactions
Domard, A. (1987) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(87)90033-x · Cited by 355
(C) Means to enhance penetration
Scott Swenson, E., & Curatolo, W. J. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90015-i · Cited by 314
Intestinal Permeability Enhancement: Efficacy, Acute Local Toxicity, and Reversibility
Swenson, E. S., Milisen, W. B., & Curatolo, W. (1994) · Pharmaceutical Research · doi:10.1023/a:1018984731584 · Cited by 251
Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes
Lappalainen, K., Jääskeläinen, I., Syrjänen, K., Urtti, A., & Syrjänen, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018932714745 · Cited by 238
Cited by
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Hydrogel nanoparticles in drug delivery
Hamidi, M., Azadi, A., & Rafiei, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.002 · Cited by 2,067
Biodegradation, biodistribution and toxicity of chitosan
Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Functional Characterization of Chitin and Chitosan
Aranaz, I., Mengibar, M., Harris, R., Panos, I., Miralles, B., Acosta, N., Galed, G., & Heras, A. (2009) · Current Chemical Biology · doi:10.2174/187231309788166415 · Cited by 1,214
Chitosan microspheres as a potential carrier for drugs
Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., & Dhawan, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.026 · Cited by 1,128
Chitosan-based drug delivery systems
Bernkop-Schnürch, A., & Dünnhaupt, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.007 · Cited by 991
Current status of polymeric gene delivery systems☆
PARK, T., JEONG, J., & KIM, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.007 · Cited by 944
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Huang, M., Khor, E., & Lim, L.-Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016249.52831.a5 · Cited by 853
Chitosan: some pharmaceutical and biological aspects - an update
Singla, A. K., & Chawla, M. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776441 · Cited by 784
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681
Pharmaceutical applications of chitosan
Dodane, V., & Vilivalam, V. D. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00059-5 · Cited by 663
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.58.1423 · Cited by 660
Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery
MacLaughlin, F. C., Mumper, R. J., Wang, J., Tagliaferri, J. M., Gill, I., Hinchcliffe, M., & Rolland, A. P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00097-2 · Cited by 601
Effect of chitosan on epithelial permeability and structure
Dodane, V (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 578
Elgadir, M. A., Uddin, M. S., Ferdosh, S., Adam, A., Chowdhury, A. J. K., & Sarker, M. Z. I. (2015) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.10.008 · Cited by 536
Köping-Höggård, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Vårum, K., & Artursson, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301492 · Cited by 532
Self-citationChitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Wu, Y., Yang, W., Wang, C., Hu, J., & Fu, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.042 · Cited by 517
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Bioavailability enhancers of herbal origin: An overview
Kesarwani, K., & Gupta, R. (2013) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60060-x · Cited by 498
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Chitosan and its derivatives in mucosal drug and vaccine delivery
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00172-5 · Cited by 456
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery
Aibani, N., Rai, R., Patel, P., Cuddihy, G., & Wasan, E. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101686 · Cited by 419
Progress in brain targeting drug delivery system by nasal route
Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402
Uptake of FITC-Chitosan Nanoparticles by A549 Cells
Huang, M., Ma, Z., Khor, E., & Lim, L.-Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1020404615898 · Cited by 390
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Rodrigues, S., Dionísio, M., López, C. R., & Grenha, A. (2012) · Journal of Functional Biomaterials · doi:10.3390/jfb3030615 · Cited by 389
Influence of molecular weight on oral absorption of water soluble chitosans
Chae, S. Y., Jang, M.-K., & Nah, J.-W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.012 · Cited by 383
Intestinal permeation enhancers for oral peptide delivery
Maher, S., Mrsny, R. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.005 · Cited by 381
Chitosan-based drug nanocarriers: Where do we stand?
Garcia-Fuentes, M., & Alonso, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.017 · Cited by 353
The potential of chitosan in ocular drug delivery
Alonso, M. J., & Sánchez, A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022476 · Cited by 352
Vander, P., Vårum, K. M., Domard, A., Eddine El Gueddari, N., & Moerschbacher, B. M. (1998) · Plant Physiology · doi:10.1104/pp.118.4.1353 · Cited by 339
Self-citationTransmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Lindmark, T., Kimura, Y., & Artursson, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37216-7 · Cited by 333
Self-citationTrimethyl chitosan and its applications in drug delivery
Mourya, V. K., & Inamdar, N. N. (2009) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-008-3659-z · Cited by 316
Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., & Muranishi, S. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970018g · Cited by 314
Chitosan–PEG nanocapsules as new carriers for oral peptide delivery
Prego, C., Torres, D., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.015 · Cited by 308
Chitosan nanoparticles: a survey of preparation methods
Grenha, A. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.654121 · Cited by 305
Takeuchi, H., Matsui, Y., Yamamoto, H., & Kawashima, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00411-x · Cited by 290
Dyer, A. M., Hinchcliffe, M., Watts, P., Castile, J., Jabbal-Gill, I., Nankervis, R., Smith, A., & Illum, L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016418523014 · Cited by 280
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Self-citationAbsorption Enhancers for Nasal Drug Delivery
Davis, S. S., & Illum, L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00003 · Cited by 264
Natural Polysaccharide Nanomaterials: An Overview of Their Immunological Properties
Torres, F. G., Troncoso, O. P., Pisani, A., Gatto, F., & Bardi, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205092 · Cited by 261
van der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.023 · Cited by 260
Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
Vllasaliu, D., Exposito-Harris, R., Heras, A., Casettari, L., Garnett, M., Illum, L., & Stolnik, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.020 · Cited by 252
Kotzé, A. F., Lueßen, H. L., de Leeuw, B. J., de Boer, (. G., Coos Verhoef, J., & Junginger, H. E. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00154-5 · Cited by 226
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review
Rassu, G., Soddu, E., Cossu, M., Gavini, E., Giunchedi, P., & Dalpiaz, A. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.05.002 · Cited by 87
Schöll, I., Boltz-Nitulescu, G., & Jensen-Jarolim, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.020 · Cited by 51
Metadata
- Authors
- Schipper, N. G. M., Vårum, K. M., & Artursson, P.
- Venue
- Pharmaceutical Research
- Published
- 1996-11
- Volume
- 13
- Issue
- 11
- Pages
- 1686-1692
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1541781779
- Cited by
- 384
- References
- 18
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.